Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Acetyl L-carnitine (ALC) has been studied for its potential to support or treat numbness, particularly that associated with peripheral neuropathy. Peripheral neuropathy is a condition often characterized by numbness, tingling, and pain, commonly resulting from diabetes, chemotherapy, or other causes. Several randomized controlled trials and meta-analyses have investigated the efficacy of ALC in neuropathic conditions. The evidence suggests ALC can help improve nerve function and reduce symptoms such as numbness and pain, most notably in diabetic and chemotherapy-induced neuropathy.

A 2008 meta-analysis published in Diabetes Care reviewed multiple clinical trials and found that ALC significantly improved nerve conduction velocity and reduced neuropathic pain in diabetic patients. Similarly, a 2013 review in CNS Drugs concluded that ALC was effective in reducing symptoms of peripheral neuropathy, including numbness, particularly when used over several months. The proposed mechanism involves ALC’s neuroprotective effects, support of mitochondrial function, and possible promotion of nerve regeneration.

While the evidence is strongest for neuropathic pain, many of these studies also measured numbness as a symptom and observed improvements. However, the magnitude of benefit varies, and not all patients respond. Overall, the evidence base is moderate, with most support coming from clinical trials in neuropathic conditions rather than general numbness of unknown cause.

More about Acetyl L-carnitine
More about Numbness

Other ingredients used for Numbness

Other health conditions supported by Acetyl L-carnitine

Products containing Acetyl L-carnitine

Nature's Sunshine Solstic Cardio